Aldeyra Therapeutics (ALDX) Shares Outstanding (Diluted) (2013 - 2026)
Aldeyra Therapeutics (ALDX) Shares Outstanding (Diluted) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | 52.24 Mn |
| 2 | Nanobiotix | 1,933.35 Bn | 1,933.29 Bn | - | - |
| 3 | Akari Therapeutics | 1,063.56 Bn | 1,063.56 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 468.54 Bn | 463.75 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.20 Bn | 2.59 Bn | 256.30 Mn |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 63.57 Bn | 63.57 Bn | - | 680.00 |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | 64.41 Mn |
| 9 | Alnylam Pharmaceuticals | 37.75 Bn | 34.74 Bn | 959.66 Mn | 138.23 Mn |
| 10 | Aldeyra Therapeutics | 94.70 Mn | 94.70 Mn | - | 60.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.32 Mn |
| Dec 31, 2025 | 60.06 Mn |
| Sep 30, 2025 | 60.13 Mn |
| Jun 30, 2025 | 60.05 Mn |
| Mar 31, 2025 | 59.89 Mn |
| Dec 31, 2024 | 59.48 Mn |
| Sep 30, 2024 | 59.53 Mn |
| Jun 30, 2024 | 59.41 Mn |
| Mar 31, 2024 | 59.41 Mn |
| Dec 31, 2023 | 58.94 Mn |
| Sep 30, 2023 | 58.99 Mn |
| Jun 30, 2023 | 58.79 Mn |
| Mar 31, 2023 | 58.79 Mn |
| Dec 31, 2022 | 58.41 Mn |
| Sep 30, 2022 | 58.46 Mn |
| Jun 30, 2022 | 58.30 Mn |
| Mar 31, 2022 | 58.30 Mn |
| Dec 31, 2021 | 54.04 Mn |
| Sep 30, 2021 | 58.02 Mn |
| Jun 30, 2021 | 54.28 Mn |